"I am not saying they did anything wrong by having a small sample size, the truth is, you often get small sample sizes for rare cancer studies. " I literally said that here: 58505142
What they need to do is look at 23.8% compared to chemotherapy alone for nonresectable pancreatic cancer patients, and the likelihood of resection post first line therapy. That would be the comparison which tells us which is better.
OSL Price at posting:
4.3¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)